Navigation Links
WallSt.net (www.wallst.net) Updates the Investment Community Through All-New Interviews With XMDC, POSS and TYPE
Date:10/18/2007

NEW YORK, Oct. 18 /PRNewswire/ -- On October 2, Paul Lisenby, Chairman and CEO of XTend Medical Corp. (Pink Sheets: XMDC) updated the investment community in an all-new interview with http://www.wallst.net. Interview highlights include detailed discussions on the following topics:

-- focus on creating medical technologies for the diabetes market

-- demographic trends bolstering the company's growth prospects

-- management bios

-- how strategic partnerships play a role in the company's growth

-- reasons the company's solutions have a competitive edge

-- upcoming milestones for investors to watch for

To hear the interview in its entirety, and to read an in-depth report on the company, visit http://www.wallst.net/superstocks/superstocks_profile.asp?ticker=xmdc

On October 5, Jules Fisher, Chief Financial Officer for Possis Medical, Inc. (Nasdaq: POSS) (http://www.possis.com) updated the investment community in an all-new interview with http://www.wallst.net. Interview highlights include detailed discussions on the following topics:

-- how the company was able to offset the decline from its coronary

business

-- moving into a "recovery mode"

-- reasons the company is "behaving like a growth company again"

-- market opportunities for the company's medical technology solutions

-- upcoming milestones for investors to watch for

To hear the interview in its entirety, visit http://www.wallst.net/audio/audio.asp?ticker=POSS&id=3977

On October 4, Douglas Shaw, CEO of Monotype Imaging Holdings, Inc. (Nasdaq: TYPE) (http://www.monotypeimaging.com) updated the investment community in an all-new interview with http://www.wallst.net. Interview highlights include detailed discussions on the following topics:

-- how the company combines technology and typefaces

-- applications for the company text imaging solutions

-- distribution channels for licensing business

-- industry trends bolstering the company's growth prospects

-- upcoming milestones for investors to watch for

To hear the interview in its entirety, visit http://www.wallst.net/audio/audio.asp?ticker=TYPE&id=3962

About WallSt.net:

http://www.wallst.net is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc. (http://www.financialmediagroupinc.com). The Web site is a leading provider of timely business news, executive interviews, multimedia content and research tools. Financial Media Group, Inc. also owns http://www.mywallst.net, a financial social network for investors, and Financial Filings Corp. (http://www.financialfilings.com), a provider of media and compliance solutions to publicly traded companies. In addition to WallSt.net, WallStreet Direct, Inc. owns and operates WallStRadio (http://www.wallstradio.com), a business and finance podcast Web site. We have received one million two hundred fifty thousand restricted shares of XMDC from XTend Medical Corp. for media and advertising services. For a complete list of our advertisers, and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.asp.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050927/LATU121LOGO)

CONTACT:

WallSt.net

800-4-WALLST


'/>"/>
SOURCE WallStreet Direct, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. WHO Updates Outdated Pediatric Growth Charts
2. China Doubles Its Investment In AIDS/HIV Treatment.
3. Biocon To Raise Its Investment In Scotland
4. Cocoa Treats: Chocolates, as a Health Investment? Chew on this!
5. Varicose Vein Treatments Turn Out To Be A Viable Health Investment
6. WHO calls for big investment in tests for TB
7. China Opens Doors For Foreign Investments In Hospitals Care System
8. Fidel Castro Appeals for Investment in Health Rather Than in Arms
9. International community warns India on HIV situation
10. Medical community worried that new curriculum will Promote Quackery
11. Wangaratta Community fundraising for Herceptin drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Infertility ... in pelvic conditions and has helped many women become pregnant upon treating their ... of office-based and simple outpatient evaluations. We can provide the necessary information ...
(Date:4/26/2017)... NJ (PRWEB) , ... April 26, 2017 , ... RawTrition ... an easy way to get nutrients from SUPERFOODS! , RawTrition is taking ... at the cellular level because the body recognizes its raw form (unlike the synthetically ...
(Date:4/26/2017)... LOUIS (PRWEB) , ... April 26, 2017 , ... ... designed specifically to improve the profitability of ready-to-drink, high-protein beverages by helping beverage ... economic alternative to dairy proteins, providing direct cost savings as well as more ...
(Date:4/26/2017)... Gainesville, FL (PRWEB) , ... April 26, 2017 ... ... health and human performance, is proud to announce that it has received 510(k) ... cutting-edge technologies, the MyoCycle Home and the MyoCycle Pro. , Both devices are ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... Mirroring360 Pro . This new addition to the Mirroring360 product family combines ... and business. , Mirroring360 Pro enables educators, business professionals and individuals to stream ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Vivify Health, the ... devices, has been awarded a very significant patent for ... EMRs to continual care via digital health.  This landmark ... intellectual property and further secures Vivify,s position as the ... in 2009, was the first company to apply consumer ...
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals ... innovative therapeutics that address significant unmet medical needs, ... from the Company,s consumer product development program, based ... the Society for Investigative Dermatology (SID) 76 th ... advance and promote the sciences relevant to skin ...
(Date:4/20/2017)... April 20, 2017   ZappRx, Inc ., a digital ... prescribing process, today announced it closed $25 million in Series ... capital firm based in Seattle that ... Partners . The Series B round included participation from ... 2014, and GV (formerly Google Ventures). As part ...
Breaking Medicine Technology: